Radiology, Vol 178, 79-82, Copyright © 1991 by Radiological Society of North America

ARTICLES

Hepatobiliary MR imaging: first human experience with MnDPDP

KO Lim, DD Stark, PT Leese, A Pfefferbaum, SM Rocklage and SC Quay
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA.

The first human MR imaging results for the hepatobiliary contrast agent manganese(II)N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'- bis(phosphate) (MnDPDP) are reported. MnDPDP is a paramagnetic contrast agent specific for hepatobiliary imaging. An imaging study was performed to investigate the presence of contrast enhancement or facilitated visualization of normal structures. Twelve healthy subjects receiving MnDPDP at doses of 3, 10, or 15 mumol/kg were imaged after injection for approximately 30 minutes at 1-5-minute intervals. Transaxial abdominal images were obtained at 1.5 T in a single breath- hold interval of 21 seconds with use of a spin-echo pulse sequence (repetition time = 150 msec, echo time = 20 msec). Liver parenchyma enhancement was observed 1 minute after injection and persisted for at least 30 minutes. Clearance into the gallbladder was visualized within 15 minutes. Enhancement was dose-dependent; a dose of 10 mumol/kg produced a 75%-100% signal enhancement of the liver at 10 minutes after injection.

This article has been cited by other articles:

				D.-M. Koh, G. Brown, Z. Meer, A. R. Norman, and J. E. Husband Diagnostic Accuracy of Rim and Segmental MRI Enhancement of Colorectal Hepatic Metastasis After Administration of Mangafodipir Trisodium Am. J. Roentgenol., February 1, 2007; 188(2): W154 - W161. [Abstract] [Full Text] [PDF]

				S. N. Gandhi, M. A. Brown, J. G. Wong, D. A. Aguirre, and C. B. Sirlin MR Contrast Agents for Liver Imaging: What, When, How RadioGraphics, November 1, 2006; 26(6): 1621 - 1636. [Abstract] [Full Text] [PDF]

				N. Hottat, C. Winant, T. Metens, N. Bourgeois, J. Deviere, and C. Matos MR Cholangiography with Manganese Dipyridoxyl Diphosphate in the Evaluation of Biliary-Enteric Anastomoses: Preliminary Experience Am. J. Roentgenol., May 1, 2005; 184(5): 1556 - 1562. [Abstract] [Full Text] [PDF]

				H. K. Ryeom, B. H. Choe, J. Y. Kim, S. Kwon, C. W. Ko, H. M. Kim, S. B. Lee, and D. S. Kang Biliary Atresia: Feasibility of Mangafodipir Trisodium-enhanced MR Cholangiography for Evaluation Radiology, April 1, 2005; 235(1): 250 - 258. [Abstract] [Full Text] [PDF]

				K. M. Vitellas, A. El-Dieb, K. K. Vaswani, W. F. Bennett, J. Fromkes, C. Ellison, and J. G. Bova Using Contrast-Enhanced MR Cholangiography with IV Mangafodipir Trisodium (Teslascan) to Evaluate Bile Duct Leaks After Cholecystectomy: A Prospective Study of 11 Patients Am. J. Roentgenol., August 1, 2002; 179(2): 409 - 416. [Abstract] [Full Text] [PDF]

				G. T. Sica, H. Ji, and P. R. Ros CT and MR Imaging of Hepatic Metastases Am. J. Roentgenol., March 1, 2000; 174(3): 691 - 698. [Full Text] [PDF]